How to break through in the competition?

[market analysis of chinapharma.com] "the possibility of policy liberalization of traditional Chinese medicine formula granules industry is increasing, and enterprises with process and quality standards will have an outbreak of sales scale and market coverage." Industry insiders said so Traditional Chinese medicine formula granule is an important achievement and symbol of the modernization of traditional Chinese medicine Compared with traditional Chinese medicine, it does not need to be decocted, and can be taken directly with boiling water, which adapts to the modern fast-paced lifestyle, so it is favored by patients According to the report on the completion of the main economic indicators of the pharmaceutical industry in the first half of 2017 issued by the Department of consumer goods industry of the Ministry of industry and information technology, the sales volume of Enterprises above the designated size in the Chinese traditional medicine industry in the first half of 2017 was about 438.7 billion yuan Among them, the revenue from the processing business of Chinese herbal pieces (including formula granules) is 104.7 billion yuan; in the first half of 2018, the revenue from the formula granules of Chinese herbal medicines is 3.49 billion yuan, the gross profit is 2.04 billion yuan, and the net profit is 630 million yuan In general, the formula particles in China show a trend of accelerated growth and a considerable market prospect The policy of traditional Chinese medicine formula granule industry is good and the standard is the guarantee of quality Without high standard, there will be no high quality The author understands that in order to promote the construction of the standard of traditional Chinese medicine formula granules, the special plan for scientific and technological innovation of traditional Chinese Medicine issued by China during the 13th five year plan clearly stipulates: systematically study the extraction process and quality standard of 100 kinds of traditional Chinese medicine formula granules, carry out the quality control research on the production line of formula granules, form the unified production process and test standard in China; carry out 20 kinds of Decoction To evaluate the effectiveness and safety of decoction, formula granules and whole granules, to verify the consistency of the efficacy of traditional Chinese medicine formula granules and traditional "co Decoction" decoction; to carry out the preparation and standard research of 30-50 commonly used clinical classic formula standard granules, to establish the production process and parameter control system to meet the needs of industrial production, and to form a stable market supply capacity In addition, under the policy guidance of "made in China 2025" and "healthy China 2030" plan outline ", it is also conducive to the layout of large health industry of Chinese pharmaceutical enterprises, to build more traditional Chinese medicine brands, and to promote the modernization and internationalization of traditional Chinese medicine Meanwhile, one belt, one road strategy also brings new opportunities to the internationalization of Chinese medicine With the support of national policies, the Chinese medicine industry ushered in the spring It can be said that with the support of many favorable policies of the state, the traditional Chinese medicine formula granule industry also ushered in good development opportunities But at the same time, the competition among the enterprises of traditional Chinese medicine formula granules is more and more fierce In order to win the initiative in the market, many enterprises have to explore and innovate In the competition, the enterprise seeks to break through the "transformation from manufacturing to" intelligent ", so that the production of the enterprise can be upgraded from artificial mode to automatic and intelligent mode, so as to truly move towards the industrial 4 era." Some in the industry said so It is reported that in the field of traditional Chinese medicine formula granules, the automatic and intelligent production mode is conducive to the rapid and safe production of products, saving labor costs and error rate, improving production and management level, and suitable for large-scale production of enterprises In order to grasp the trend of intelligence, many domestic enterprises of traditional Chinese medicine granules have taken actions For example, HongRi pharmaceutical industry actively responds to the national strategy of promoting the development of traditional Chinese medicine "to promote the formation of new momentum in the optimization and upgrading of traditional industries" and the coordinated development strategy of Beijing Tianjin Hebei, docking "made in China 2025", establishing the intelligent manufacturing industrial base of traditional Chinese medicine formula granules, and realizing the integration of production management, quality control, warehousing logistics and operation For example, under the guidance of "made in China 2025", Tianshili implemented the "modern intelligent manufacturing of traditional Chinese medicine" project, transformed and improved the traditional manufacturing methods of traditional Chinese medicine, created the international intelligent manufacturing mode of modern traditional Chinese medicine, upgraded the single machine parallel and quantity replication scale production mode to the continuous production mode, and improved the intelligent level of workshop equipment and facilities In addition to grasping the development trend of policy and industry, pharmaceutical enterprises in the production of traditional Chinese medicine formula granules should also pay attention to inheritance and innovation, including technological innovation For example, some pharmaceutical enterprises study the traditional processing technology and modern equipment processing of medicinal materials, and verify the processing technology by varieties, so as to realize the organic combination of tradition and innovation.